159 related articles for article (PubMed ID: 26606739)
1. Serum protein biomarkers relevant to hepatocellular carcinoma and their detection.
Waidely E; Al-Yuobi AR; Bashammakh AS; El-Shahawi MS; Leblanc RM
Analyst; 2016 Jan; 141(1):36-44. PubMed ID: 26606739
[TBL] [Abstract][Full Text] [Related]
2. Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma.
Zhao Y; Wang M; Cui C; Zhang L; Liao F; Li H; Wu X
Cancer Biomark; 2015; 15(5):677-83. PubMed ID: 26406957
[TBL] [Abstract][Full Text] [Related]
3. Serological tumor markers of hepatocellular carcinoma: a meta-analysis.
Hussein TD
Int J Biol Markers; 2015 Feb; 30(1):e32-42. PubMed ID: 25450646
[TBL] [Abstract][Full Text] [Related]
4. Analysis of serum α-fetoprotein-L3% and des-γ carboxyprothrombin markers in cases with misleading hepatocellular carcinoma total α-fetoprotein levels.
Hadziyannis E; Sialevris K; Georgiou A; Koskinas J
Oncol Rep; 2013 Feb; 29(2):835-9. PubMed ID: 23174906
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
Bertino G; Neri S; Bruno CM; Ardiri AM; Calvagno GS; Malaguarnera M; Toro A; Malaguarnera M; Clementi S; Bertino N; Di Carlo I
Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346
[TBL] [Abstract][Full Text] [Related]
6. Serum markers of hepatocellular carcinoma.
Malaguarnera G; Giordano M; Paladina I; Berretta M; Cappellani A; Malaguarnera M
Dig Dis Sci; 2010 Oct; 55(10):2744-55. PubMed ID: 20339916
[TBL] [Abstract][Full Text] [Related]
7. Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.
Nakao A; Virji A; Iwaki Y; Carr B; Iwatsuki S; Starzl E
Hepatogastroenterology; 1991 Oct; 38(5):450-3. PubMed ID: 1722483
[TBL] [Abstract][Full Text] [Related]
8. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Morota K; Nakagawa M; Sekiya R; Hemken PM; Sokoll LJ; Elliott D; Chan DW; Dowell BL
Clin Chem Lab Med; 2011 Apr; 49(4):711-8. PubMed ID: 21231906
[TBL] [Abstract][Full Text] [Related]
9. Present and future possibilities for early diagnosis of hepatocellular carcinoma.
Stefaniuk P; Cianciara J; Wiercinska-Drapalo A
World J Gastroenterol; 2010 Jan; 16(4):418-24. PubMed ID: 20101765
[TBL] [Abstract][Full Text] [Related]
10. Enhanced detection of hepatocellular carcinoma.
el-Houseini ME; Mohammed MS; Elshemey WM; Hussein TD; Desouky OS; Elsayed AA
Cancer Control; 2005 Oct; 12(4):248-53. PubMed ID: 16258497
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for Hepatocellular Carcinoma (HCC): An Update.
Li D; Satomura S
Adv Exp Med Biol; 2015; 867():179-93. PubMed ID: 26530367
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellualar carcinoma serum markers.
Bertino G; Ardiri A; Malaguarnera M; Malaguarnera G; Bertino N; Calvagno GS
Semin Oncol; 2012 Aug; 39(4):410-33. PubMed ID: 22846859
[TBL] [Abstract][Full Text] [Related]
13. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
14. Current clinical uses of the biomarkers for hepatocellular carcinoma.
Huang J; Zeng Y
Drug Discov Ther; 2014 Apr; 8(2):98-9. PubMed ID: 24815586
[TBL] [Abstract][Full Text] [Related]
15. Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time?
Montagnana M; Danese E; Lippi G
Clin Chim Acta; 2015 May; 445():161-6. PubMed ID: 25840050
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma tumour markers: current role and expectations.
Rich N; Singal AG
Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):843-53. PubMed ID: 25260312
[TBL] [Abstract][Full Text] [Related]
17. Serum markers of hepatocellular carcinoma.
Spangenberg HC; Thimme R; Blum HE
Semin Liver Dis; 2006 Nov; 26(4):385-90. PubMed ID: 17051452
[TBL] [Abstract][Full Text] [Related]
18. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers for the early diagnosis of hepatocellular carcinoma.
Tsuchiya N; Sawada Y; Endo I; Saito K; Uemura Y; Nakatsura T
World J Gastroenterol; 2015 Oct; 21(37):10573-83. PubMed ID: 26457017
[TBL] [Abstract][Full Text] [Related]
20. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
Wong RJ; Ahmed A; Gish RG
Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]